These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7585758)

  • 1. Successful treatment of hyponatremia with angiotensin-converting enzyme inhibitors in patients with congestive heart failure.
    Elisaf M; Theodorou J; Pappas C; Siamopoulos K
    Cardiology; 1995; 86(6):477-80. PubMed ID: 7585758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal effects of angiotensin-converting enzyme inhibition in cardiac failure.
    Dzau VJ
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):74-80. PubMed ID: 3037893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation between serum sodium levels and prognosis in outpatients with chronic heart failure: neutral effect of treatment with beta-blockers and angiotensin-converting enzyme inhibitors: data from the Italian Network on Congestive Heart Failure (IN-CHF database).
    Baldasseroni S; Urso R; Orso F; Bianchini BP; Carbonieri E; Cirò A; Gonzini L; Leonardi G; Marchionni N; Maggioni AP;
    J Cardiovasc Med (Hagerstown); 2011 Oct; 12(10):723-31. PubMed ID: 21873881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction of dilutional hyponatremia in severe chronic heart failure by converting-enzyme inhibition.
    Packer M; Medina N; Yushak M
    Ann Intern Med; 1984 Jun; 100(6):782-9. PubMed ID: 6326629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative haemodynamic responses to the first dose of short- and long-acting ACE inhibitors in patients with congestive heart failure.
    Anthopoulos L; Apostolou T; Bonoris P; Foussas S; Lefkos N; Zombolos S
    Curr Med Res Opin; 2001; 17(4):290-7. PubMed ID: 11922403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A three year clinical review of the impact of angiotensin converting enzyme inhibitors on the intra hospital mortality of congestive heart failure in Nigerians.
    Adewole AD; Ikem RT; Adigun AQ; Akintomide AO; Balogun MO; Ajayi AA
    Cent Afr J Med; 1996 Aug; 42(8):253-5. PubMed ID: 8990572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of hyponatremia as a risk factor for the development of functional renal insufficiency during converting enzyme inhibition in severe chronic heart failure.
    Packer M; Lee WH; Kessler PD; Medina N; Yushak M; Gottlieb SS
    J Am Coll Cardiol; 1987 Oct; 10(4):837-44. PubMed ID: 2821091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal response to captopril in severe heart failure: role of furosemide in natriuresis and reversal of hyponatremia.
    Dzau VJ; Hollenberg NK
    Ann Intern Med; 1984 Jun; 100(6):777-82. PubMed ID: 6372563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors.
    van Wijngaarden J; Smit AJ; de Graeff PA; van Gilst WH; van der Broek SA; van Veldhuisen DJ; Lie KI; Wesseling H
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):240-5. PubMed ID: 7511753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
    Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A correctable complication of advanced congestive heart failure.
    Valle GA; Lemberg L
    Heart Lung; 1987 Mar; 16(2):224-6. PubMed ID: 3546209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACE inhibitors in congestive heart failure.
    Riegger AJ
    Cardiology; 1989; 76 Suppl 2():42-9. PubMed ID: 2670220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of angiotensin-converting enzyme inhibitors in congestive heart failure.
    Galvao M
    Heart Lung; 1990 Sep; 19(5 Pt 1):505-11. PubMed ID: 2211159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of angiotensin-converting enzyme inhibitors in patients with left ventricular systolic dysfunction and hyponatremia.
    Balling L; Kober L; Schou M; Torp-Pedersen C; Gustafsson F
    J Card Fail; 2013 Nov; 19(11):725-30. PubMed ID: 24263115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy with ACE inhibitors in chronic heart failure and limited kidney function].
    Osterziel KJ; Nagel F; Dietz R
    Z Kardiol; 1994; 83 Suppl 4():81-7. PubMed ID: 7856286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Captopril and spironolactone therapy for refractory congestive heart failure.
    Dahlström U; Karlsson E
    Am J Cardiol; 1993 Jan; 71(3):29A-33A. PubMed ID: 8422001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lisinopril in the treatment of congestive heart failure.
    Giles TD
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():83-7. PubMed ID: 2550647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low serum sodium as a poor prognostic indicator for mortality in congestive heart failure patients.
    DeWolfe A; Lopez B; Arcement LM; Hebert K
    Clin Cardiol; 2010 Dec; 33(12):E13-7. PubMed ID: 21184540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of captopril and lisinopril on circadian blood pressure rhythm and renal function in mild-to-moderate heart failure.
    Osterziel KJ; Karr M; Lemmer B; Dietz R
    Am J Cardiol; 1992 Oct; 70(10):147C-150C. PubMed ID: 1329473
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.